ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting miR-30d reverses pathological cardiac hypertrophy

Li, Jin; Sha, Zhao; Zhu, Xiaolan; Xu, Wanru; Yuan, Weilin; Yang, Tingting; Jin, Bing; Yan, Yuwei; Chen, Rui; Wang, Siqi; Yao, Jianhua; Xu, Jiahong; Wang, Zitong; Li, Guoping; Das, Saumya; Yang, Liming*; Xiao, Junjie*上海大学; 哈尔滨医科大学; 同济大学; 6
EBioMedicine2022-7DOI: 10.1016/j.ebiom.2022.104108
13被引5阅读
引用收藏
分享

摘要

Background Pathological cardiac hypertrophy occurs in response to numerous stimuli and precedes heart failure (HF). Therapies that ameliorate pathological cardiac hypertrophy are highly needed. Methods The expression level of miR-30d was analyzed in hypertrophy models and serum of patients with chronic heart failure by qRT-PCR. Gain and loss-of-function experiments of miR-30d were performed in vitro. miR-30d gain of function were performed in vivo. Bioinformatics, western blot, luciferase assay, qRT-PCR, and immunofluorescence were performed to examine the molecular mechanisms of miR-30d. Findings miR-30d was decreased in both murine and neonatal rat cardiomyocytes (NRCMs) models of hypertrophy. miR-30d overexpression ameliorated phenylephrine (PE) and angiotensin II (Ang II) induced hypertrophy in NRCMs, whereas the opposite phenotype was observed when miR-30d was downregulated. Consistently, the miR-30d transgenic rat was found to protect against isoproterenol (ISO)-induced pathological hypertrophy. Mechanistically, methyltransferase EZH2 could promote H3K27me3 methylation in the promotor region of miR-30d and suppress its expression during the pathological cardiac hypertrophy. miR-30d prevented pathological cardiac hypertrophy via negatively regulating its target genes MAP4K4 and GRP78 and inhibiting pro-hypertrophic nuclear factor of activated T cells (NFAT). Adeno-associated virus (AAV) serotype 9 mediated-miR-30d overexpression exhibited beneficial effects in murine hypertrophic model. Notably, miR-30d was reduced in serum of patients with chronic heart failure and miR-30d overexpression could significantly ameliorate pathological hyper-trophy in human embryonic stem cell-derived cardiomyocytes. Interpretation Overexpression of miR-30d may be a potential approach to treat pathological cardiac hypertrophy.

学科与关键词

关键词
Pathological cardiac hypertrophymiR-30dTranslational research
相关
加载中…
  • Diverging targets mediate the pathological role of miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
    Zeng, Ni; Huang, Yu-Qing; Yan, Yu-Min; Hu, Zhi-Qin; Zhang, Zhuo; Feng, Jia-Xin; Guo, Ji-Shen; Zhu, Jie-Ning; Fu, Yong-Heng; Wang, Xi-Pei; Zhang, Meng-Zhen; Duan, Jin-Zhu; Zheng, Xi-Long; Xu, Jin-Dong*; Shan, Zhi-Xin*Molecular Therapy-Nucleic Acids, 2021, 26: 1035-1050.被引 15
  • FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway
    Zhang, Yue; Sun, Mengxian; Wang, Dongwei; Hu, Yaju; Wang, Ruonan; Diao, Hongtao; Shao, Xiaoqi; Li, Yun; Li, Xu; Leng, Mingyang; Wang, Lexun; Yan, Meiling; Rong, Xianglu; Guo, Jiao*Biomedicine and Pharmacotherapy, 2022, 148: 112696.被引 5
  • MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2
    Zhang, Yue; Wang, Zhiying; Lan, Dingming; Zhao, Jingjing; Wang, Lexun; Shao, Xiaoqi; Wang, Dongwei; Wu, Kaili; Sun, Mengxian; Huang, Xueying; Yan, Meiling; Liang, Haihai; Rong, Xianglu; Diao, Hongtao*; Guo, Jiao*Pharmacological Research, 2022, 177: 106124.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
EBioMedicine
发表日期
2022-07
卷期
第 81 卷
页码
104108
DOI
10.1016/j.ebiom.2022.104108
期刊等级
1区
成果收录
SCIE
资助标注
National Key Research and Development Project [2018YFE0113500]; National Natural Science Foundation of China [82020108002, 81900359]; Science and Technology Commission of Shanghai Municipality [20DZ2255400, 21XD1421300, 22010500200]; Shanghai Sailing Program [19YF1416400]; Program of Shanghai Education Commission [19SG34]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [19CG45]

作者

  • L

    Li, Jin (第一作者)

    6 · shanghai univ

  • S

    Sha, Zhao

    6 · shanghai univ

查看全部 17 位作者收起作者
  • Z

    Zhu, Xiaolan

    6 · shanghai univ

  • X

    Xu, Wanru

    6 · shanghai univ

  • Y

    Yuan, Weilin

    6 · shanghai univ

  • Y

    Yang, Tingting

    6 · shanghai univ

  • J

    Jin, Bing

    6 · shanghai univ

  • Y

    Yan, Yuwei

    6 · shanghai univ

  • C

    Chen, Rui

    6 · shanghai univ

  • W

    Wang, Siqi

    6 · shanghai univ

  • Y

    Yao, Jianhua

    tongji univ

  • X

    Xu, Jiahong

    tongji univ

  • W

    Wang, Zitong

    harbin med univ

  • L

    Li, Guoping

  • D

    Das, Saumya

  • Y

    Yang, Liming (通讯)

    harbin med univ

  • X

    Xiao, Junjie (通讯)

    shanghai univ · 6

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417